Instead, other reports show that ALOX5 may have opposite roles in a different context that it promoted BCR-ABL driven B-cell acute lymphoblastic leukemia while inhibited MLL-fusion driven acute myeloid leukemia [11, 31]. Here, KMT2A is linked to B-cell acute lymphoblastic leukemia.